Cargando…
Autologous Bone Marrow–Derived Cells in the Treatment of Liver Disease Patients
Liver transplantation is universally accepted as a “cure” procedure, and yet is not universally applicable for the treatment of end-stage liver diseases (ESLD) because of the shortage of donors, operative complications, risk of rejection, and high cost. Bioartificial liver device is an option to tem...
Autores principales: | AlAhmari, Leenah S., AlShenaifi, Jumanah Y., AlAnazi, Reema A., Abdo, Ayman A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355864/ https://www.ncbi.nlm.nih.gov/pubmed/25672232 http://dx.doi.org/10.4103/1319-3767.151211 |
Ejemplares similares
-
Can the bone marrow harvest volume be reduced safely in hematopoietic stem cell transplantation with pediatric sibling donors?
por: AlAnazi, Awatif, et al.
Publicado: (2023) -
The Impact of the COVID-19 Pandemic on Coronary Interventional Cardiology Activity in King Abdulaziz Medical City: A Retrospective Study
por: AlBattal, Nouf Z, et al.
Publicado: (2023) -
Pediatric high risk neuroblastoma with autologous stem cell transplant – 20 years of experience
por: Khan, Saadiya, et al.
Publicado: (2021) -
Heterotopic Ossification Complicating Traumatic Ulnar Nerve Palsy in a Child
por: AlSahli, Alaa Mohammed, et al.
Publicado: (2022) -
Attitude of the Saudi community towards heart donation, transplantation, and artificial hearts
por: AlHabeeb, Waleed, et al.
Publicado: (2017)